Biomedical firm in £1m expansion

A biomedical firm in the North announced a cash injection of around £1m (€1.05m) today to help expand the business.

Queen’s University spin-out company i-Path Diagnostics is a leader in the delivery of innovative software technologies for education, training and research in diagnostic medicine – particularly cancer research and detection.

Announcing the investment in the four-year-old company, chairman Ian Kerr said it had been built on the North's strong knowledge economy and internet connectivity.

Most Read in Business